《T a b l\n\t\t\t\t\t\te2Mi c r o RNAs i n h u m a n p a t i e n t s w i t h Al z h e i m e r’

《T a b l\n\t\t\t\t\t\te2Mi c r o RNAs i n h u m a n p a t i e n t s w i t h Al z h e i m e r’   提示:宽带有限、当前游客访问压缩模式
本系列图表出处文件名:随高清版一同展现
《MicroRNAs as diagnostic and therapeutic tools for Alzheimer's disease: advances and limitations》


  1. 获取 高清版本忘记账户?点击这里登录
  1. 下载图表忘记账户?点击这里登录
M MSE:Mi n i-Me n t a l\n\t\t\t\t\t\tSt a t e Ex a m i\n\t\t\t\t\t\tn a t i\n\t\t\t\t\t\to n;Mo CA:Mo n\n\t\t\t\t\t\tt r e a\n\t\t\t\t\t\tl Co g\n\t\t\t\t\t\tn i t i v e As s e s s m e n t.

By qPCR validation,Ren et al.(2016)showed miR-339 and miR-425 were upregulated and miR-639 was downregulated in AD PBMNs compared with NC PBMNs.ROC indicated miR-339 as a fair test to distinguish AD PBMNs from NC PBMNs(AUC 0.768),and miR-425 to be a good test to distinguish AD PBMNs from NC PBMNs(AUC 0.868).MiR-639was a poor test to distinguish AD PBMNs from NC PBMNs(AUC 0.287).Theβ-amyloid precursor proteinβ-secretase BACE1 might be a target of miR-339 and miR-425.